<table id="_RefTABLE3" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3: Active Metabolite Pharmacokinetics and Antiplatelet Responses by CYP2C19 Metabolizer Status </caption>
<col width="18%"></col>
<col width="17%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="15%"></col>
<col width="9%"></col>
<thead>
<tr stylecode="Toprule">
<th align="left" stylecode="Botrule Toprule " valign="top"></th>
<th align="center" stylecode="Botrule Toprule " valign="top">
<content stylecode="bold">Dose</content>
</th>
<th align="center" stylecode="Botrule Toprule " valign="top">
<content stylecode="bold">Ultrarapid </content>
<br/>
<content stylecode="bold">(n=10)</content>
</th>
<th align="center" stylecode="Botrule Toprule " valign="top">
<content stylecode="bold">Extensive (n=10)</content>
</th>
<th align="center" stylecode="Botrule Toprule " valign="top">
<content stylecode="bold">Intermediate (n=10)</content>
</th>
<th align="center" stylecode="Botrule Toprule " valign="top">
<content stylecode="bold">Poor </content>
<br/>
<content stylecode="bold">(n=10)</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Toprule ">
<paragraph>Cmax (ng/mL)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>300 mg (24 h)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>24 (10)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>32 (21)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>23 (11)</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>11 (4)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td align="center">
<paragraph>600 mg (24 h)</paragraph>
</td>
<td align="center">
<paragraph>36 (13)</paragraph>
</td>
<td align="center">
<paragraph>44 (27)</paragraph>
</td>
<td align="center">
<paragraph>39 (23)</paragraph>
</td>
<td align="center">
<paragraph>17 (6)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td align="center">
<paragraph>75 mg (Day 5)</paragraph>
</td>
<td align="center">
<paragraph>12 (6)</paragraph>
</td>
<td align="center">
<paragraph>13 (7)</paragraph>
</td>
<td align="center">
<paragraph>12 (5)</paragraph>
</td>
<td align="center">
<paragraph>4 (1)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td align="center">
<paragraph>150 mg (Day 5)</paragraph>
</td>
<td align="center">
<paragraph>16 (9)</paragraph>
</td>
<td align="center">
<paragraph>19 (5)</paragraph>
</td>
<td align="center">
<paragraph>18 (7)</paragraph>
</td>
<td align="center">
<paragraph>7 (2)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>IPA (%)<footnote id="_RefIDAMHDMG">Inhibition of platelet aggregation with 5mcM ADP; larger value indicates greater platelet inhibition</footnote>
</paragraph>
</td>
<td align="center">
<paragraph>300 mg (24 h)</paragraph>
</td>
<td align="center">
<paragraph>40 (21)</paragraph>
</td>
<td align="center">
<paragraph>39 (28)</paragraph>
</td>
<td align="center">
<paragraph>37 (21)</paragraph>
</td>
<td align="center">
<paragraph>24 (26)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td align="center">
<paragraph>600 mg (24 h)</paragraph>
</td>
<td align="center">
<paragraph>51 (28)</paragraph>
</td>
<td align="center">
<paragraph>49 (23)</paragraph>
</td>
<td align="center">
<paragraph>56 (22)</paragraph>
</td>
<td align="center">
<paragraph>32 (25)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td align="center">
<paragraph>75 mg (Day 5)</paragraph>
</td>
<td align="center">
<paragraph>56 (13)</paragraph>
</td>
<td align="center">
<paragraph>58 (19)</paragraph>
</td>
<td align="center">
<paragraph>60 (18)</paragraph>
</td>
<td align="center">
<paragraph>37 (23)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td align="center">
<paragraph>150 mg (Day 5)</paragraph>
</td>
<td align="center">
<paragraph>68 (18)</paragraph>
</td>
<td align="center">
<paragraph>73 (9)</paragraph>
</td>
<td align="center">
<paragraph>74 (14)</paragraph>
</td>
<td align="center">
<paragraph>61 (14)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>VASP-PRI (%) <footnote id="_RefIDAJJDMG">Vasodilator-stimulated phosphoprotein â€“ platelet reactivity index; smaller value indicates greater platelet inhibition</footnote>
</paragraph>
</td>
<td align="center">
<paragraph>300 mg (24 h)</paragraph>
</td>
<td align="center">
<paragraph>73 (12)</paragraph>
</td>
<td align="center">
<paragraph>68 (16)</paragraph>
</td>
<td align="center">
<paragraph>78 (12)</paragraph>
</td>
<td align="center">
<paragraph>91 (12)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td align="center">
<paragraph>600 mg (24 h)</paragraph>
</td>
<td align="center">
<paragraph>51 (20)</paragraph>
</td>
<td align="center">
<paragraph>48 (20)</paragraph>
</td>
<td align="center">
<paragraph>56 (26)</paragraph>
</td>
<td align="center">
<paragraph>85 (14)</paragraph>
</td>
</tr>
<tr>
<td></td>
<td align="center">
<paragraph>75 mg (Day 5)</paragraph>
</td>
<td align="center">
<paragraph>40 (9)</paragraph>
</td>
<td align="center">
<paragraph>39 (14)</paragraph>
</td>
<td align="center">
<paragraph>50 (16)</paragraph>
</td>
<td align="center">
<paragraph>83 (13)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule "></td>
<td align="center" stylecode="Botrule ">
<paragraph>150 mg (Day 5)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>20 (10)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>24 (10)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>29 (11)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>61 (18)</paragraph>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="6" stylecode="Toprule ">
<paragraph>Values are mean (SD)</paragraph>
</td>
</tr>
</tbody>
</table>